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Resumen. - Se asume que las características biológicas de las cepas bacterianas utilizadas para test de bioactividad
tienen fuerte influencia sobre la suceptibilidad contra compuestos antibacterianos. Por lo tanto, la selección de
bacterias para pruebas microbiológicas puede acelerar conclusiones respecto al efecto de extractos y metabolitos
macroalgales sobre el crecimiento microbiano. Para probar tal presunción, se analizó la actividad biológica de
extractos crudos de 16 macroalgas del fiordo de Kiel (Alemania). Los extractos macroalgales fueron probados
frente a un set de 10 microorganismos que involucraron 5 cepas bacterianas de común uso en análisis estándar y
5 cepas de bacterias asociadas a macroalgas. Catorce macroalgas (88%) presentaron actividad antibiótica contra
al menos una cepa. Pese a la alta proporción de extractos activos, sólo 3 cepas estándar fueron susceptibles a ellos
y la actividad antibiótica fue baja (menos de 80% de inhibición). La mayoría de los extractos inhibió a Bacillus
subtilis, mientras que no hubo actividad inhibitoria frente a Erwinia amylovora, Escherichia coli y las cepas
macroalga-asociadas. Por el contrario, la totalidad de extractos estimuló el crecimiento de al menos 2 cepas
bacterianas. Mientras que la estimulación del crecimiento sobre las cepas de uso estándar fue rara (22,5%) con la
excepción del fitopatógeno Erwinia amylovora y 2 casos con Staphylococcus lentus, fue común frente a las
bacterias asociadas a macroalgas (77,5%), especialmente frente a Bacillus algicola, Pseudomonas marincola y los
dos patógenos de algas. El presente estudio demostró que los extractos macroalgales pueden producir diferentes
efectos tal como la inhibición o estimulación del crecimiento  bacteriano, dependiendo del origen de las bacterias
empleadas para los test, ya sea por el uso de un set de cepas estándar o provenientes del ambiente marino,
respectivamente.
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Abstract.- It is assumed that the biological characteristics of the bacterial strains used in bioactivity tests have
strong influences on their susceptibility against antibacterial compounds. Therefore, the selection of bacterial
test strains may rush conclusions on the effect of macroalgal extracts and metabolites on bacteria. To proof this
assumption, we have analysed the biological activities of crude extracts of 16 macroalgae from the coastal waters
of Kiel Fjord (Germany), and tested their effect against a panel of 10 microorganisms comprising 5 standard test
strains of bacteria and 5 macroalga-associated bacteria. Fourteen macroalgae (88%) displayed antibacterial
activity against at least one of the test strains. Despite the high proportion of extracts exhibiting antimicrobial
activity, only 3 strains of the standard set were susceptible to macroalgal extracts and the overall activities were
low (less than 80% of inhibition). Most of active extracts inhibited Bacillus subtilis, while no inhibition effects
were found against Erwinia amylovora, Escherichia coli, and the macroalga-associated bacteria. In contrast, all
extracts produced stimulatory growth effects of at least two of the tested bacteria. While growth stimulation of
standard set of bacteria was rare (22.5% of total tests) with exception of plant pathogen Erwinia amylovora and
two cases of Staphylococcus lentus, it was common among bacteria associated with macroalgae (77.5%), especially
Bacillus algicola, Pseudomonas marincola and both algal-pathogenic bacteria. This study demonstrates that
macroalgal extracts can display different effects, i.e., inhibition or stimulation of bacterial growth depending on
the origin of the test strains, which are derived from a standard panel or from the marine environment, respectively.
Key words: Marine algae, antibacterial activities, stimulation of bacterial growth, Kiel fjord
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INTRODUCTION
Secondary metabolites mediate numerous biological
interactions and play a particular important role in
mediating host-microbe associations in the ocean (Lane
et al. 2010). Recently, it has been addressed that chemical
interactions regulate the bacteria-macroalga relationships
and may cause specific associations (Goecke et al. 2010,
Sneed & Pohnert 2011a). Indeed, different species of
marine macroalgae growing in the same habitat under the
same environmental conditions support different bacterial
communities (Lachnit et al. 2009, Nylund et al. 2010). The
biological active compounds (both deterrents and
attractants) produced by macroalgae as well as those from
the associated bacteria may be involved in shaping these
epiphytic bacterial communities (Egan et al. 2000, Lachnit
et al. 2010).
Macroalgal chemistry is rich and diverse, spanning
most natural product classes and including functional
group characteristics found from no other source
(Maschek & Baker 2008). The antibacterial activity of
different extracts of macroalgae from almost all groups
has been described in many studies around the world
(Sridhar & Vidyavathi 1991, Hellio et al. 2000, Magallanes
et al. 2003, Freile-Pelegrin & Morales 2004, Engel et al.
2006, Lane et al. 2009, Muñoz-Ochoa et al. 2010). Although
several metabolites with antimicrobial activities have been
already characterized from macroalgae, results of different
studies on antibacterial activities of crude extracts of one
and the same species are equivocal: While some studies
reported antibacterial activities others did not (Sandsdalen
et al. 2003).
Biotic factors such as reproductive state, age of the
thallus of the macroalgae, as well as abiotic factors such
as seasonality and geographic location have influence
on the bioactivity of macroalgal extracts (Hellio et al. 2004,
Paul & Puglisi 2004, Arunkumar et al. 2010). Furthermore
there are discrepancies related to the different extraction
procedures and to the target microorganisms used in the
bioassays (Sridhar & Vidyavathi 1991, Kanagasabhapathy
et al. 2006). Unfortunately, assessments of the
antibacterial activity exhibited by macroalgae in the
natural products literature has focused on biomedically-
relevant strains, using standard microbial strains from
terrestrial origin or of medical relevance (Engel et al. 2006,
Paul et al. 2006, Hughes & Fenical 2011). Bacteria from
the marine habitat were rarely included, although
bioactivity against these would make possible to draw
conclusions in regard to the ecological role of the
substances in the macroalga-bacteria interactions
(Jormalainen & Honkanen 2008). It is expected that
macroalgae should produce antibacterial compounds
against microbial pathogens and that commensal bacteria
should be adapted to grow within the algal phycosphere
and its metabolites. Hence, the selection of bacteria for a
test panel should be relevant in order to evaluate the
ecological effects of secondary metabolites due to
different responses of the chosen bacteria.
In order to prove if a selection of ecologically relevant
bacteria results in different responses in the bioactivity
tests as compared to a standard set of bacteria, we studied
the effect of extracts from different macroalgae of the Kiel
Fjord, Germany, upon bacterial growth.
MATERIALS AND METHODS
SAMPLING OF THE MACROALGAE
Samples of 16 species belonging to 11 families of marine
macroalgae were taken from distinct sites in the Kiel Fjord,
Western Baltic Sea, Germany (54°25.5’N, 10°12’E) (Table
1). The macroalgae were collected between 1 to 6 m depth.
Until processing within 3 h after collection, the samples
were stored in the dark at ambient seawater temperature
using coolers. In the laboratory, the macroalgae were
manually cleaned from sand, epiphytes and animals, and
rinsed with sterile and filtered Baltic Sea water to remove
associated debris, planktonic and loosely attached
microorganisms.
Part of the macroalgae was fixed in 4% formaldehyde
for its taxonomic identification. Algae were identified by
examination of their thallus architecture and special
morphological characters: Fronds, branching, and
reproductive structures (Pankow 1971, Maggs &
Hommersand 1993). For the filamentous macroalgae
histological cuts were performed and observed by light
microscopy. The names of the species were used
according to Guiry & Guiry (2011). Voucher specimen were
deposited in the Herbarium of Museo Nacional de Historia
Natural, Santiago, Chile (code SGO).
MACROALGAL EXTRACT PREPARATION
Ten grams of the macroalgae were extracted by immersing
them with 200 ml dichloromethane (DCM) at room
temperature and shaking them by hand (modified method
from Nylund et al. 2005). The extracts were centrifuged at
4000 rpm for 10 min and filtered through Whatman 542
filter paper (Freile-Pelegrin & Morales 2004). All extracts
were concentrated separately under reduced pressure in
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a Speedvac RVC2-33 (Christ, Germany) until completely
dry, weighed and kept at +4°C. For further tests, 1 mg of
the solid residue was resuspended in 1 ml methanol.
ANTIMICROBIAL TESTING
The antimicrobial activity of crude extracts of macroalgae
was tested against a panel of ten microorganisms
comprising standard test strains and macroalga-
associated bacteria. The following microorganisms and
nutrient media were used:
(i) Five microorganisms usually tested in standard
laboratory tests of antibiotic activity (hereafter ‘standard
set’): Erwinia amylovora DSM 50901 (nutrient medium
M1 = 5 g l-1 peptone, 3 g l-1 meat extract in distilled water,
pH 7), Escherichia coli DSM 498 and Pseudomonas
aeruginosa DSM 50071 (both nutrient media TSB12
medium = 12 g l-1 Difco tryptic soy broth, 10 g l-1 NaCl, pH
7.2 in distilled water), as Gram-negative strains; and
Bacillus subtilis DSM 347 and Staphylococcus lentus
DSM 6672 (both nutrient media: TSB12) as representatives
of Gram-positive bacteria. All strains were obtained from
the German Collection of Microorganisms and Cell
Cultures (DSMZ, Braunschweig, Germany).
(ii) Five environmental strains that have been identified
to be associated with macroalgae in previous studies
(hereafter ‘macroalga-associated set’): iia) three isolates
were utilized which were obtained from the surface of
Baltic Sea macroalgae Fucus vesiculosus and Delesseria
sanguinea. The sampling procedure for isolating strains
of bacteria associated with the macroalgae was performed
according to Staufenberger et al. (2008). PCR
amplifications of 16S rRNA gene and subsequent
sequencing were performed at the Institute for Clinical
Molecular Biology (University Hospital Schleswig-
Holstein, Kiel, Germany). Phylogenetic analysis was
performed as described by Heindl et al. (2010). 16S rDNA
sequences of these strains (isolates AB423f, AB236d and
AB251f) were deposited at NCBI under the accession
numbers FR775437-FR775439. The isolates affiliated with
>99% 16S rRNA gene sequence similarity to other
macroalga-associated bacteria the Gram-positive Bacillus
algicola KMM 3737T (AY228462) (grown on TM: 5 g l-1
yeast extract, 1 g l-1 peptone, 30 g l-1 tropic marine sea salt
in distilled water), Paenibacillus lautus JCM 9073T
(AB073188), and the Gram-negative Pseudomonas
marincola KMM 3042T (AB301071) (grown on TSB12);
iib) Two Gram-negative bacterial strains identified as
Table 1. List of macroalgae sampled from the Kiel Fjord (Baltic Sea, Germany). Names according to Guiry & Guiry
(2011) / Lista de macroalgas del fiordo de Kiel (Mar Báltico, Alemania). Nombres según Guiry & Guiry (2011)
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macroalgal pathogens (by Sawabe et al. 1998, 2000),
Algicola bacteriolytica ATCC 700679T (‘red spot disease’)
and Pseudoalteromonas elyakovii ATCC 700519T (‘spot-
wounded fronds’), originally isolated in Japan from
diseased beds of Saccharina japonica (Areschoug) Lane
et al. (formerly Laminaria japonica). Both were
purchased from Institute Pasteur CIP (Paris, France), and
grown cultivated on nutrient medium TM.
The bioactivity tests were modified according to
Schneemann et al. (2010). Assay mixtures were prepared
by transferring 10 μl aliquots of methanolic solutions of
extracts into a sterile 96-well microtiter plate and
evaporating the solvent in a vacuum centrifuge. 200 μl
overnight cultures of each test strain were diluted to an
optical density (OD) of 0.03 determined by
spectrophotometry in the corresponding cultivation media
(see above). Cultures of the standard set were incubated
at +36°C for 5 h under constant shaking at 200 rpm except
E. amylovora at +28°C. The macroalga-associated strains
were cultivated at +28°C for 20 h; and the final OD was
determined. We corrected the natural absorbance of the
extract fractions by subtracting initial extract-only blank
values from values obtained for treatments according to
Lane et al. (2009). The tests were performed in 3  replicate
treatments. By bacterial set a total of 240 tests were
performed (16 macroalgal extracts x 5 bacterial strains x
triplicate). The resulting values were compared to those
for a positive control (100 μg ml-1 chloramphenicol) and
respective negative controls wells: solvent (‘no extract’)
and nutrient medium (‘no extract, no solvent’) on the same
plate.
RESULTS
The antimicrobial assay showed that extracts of 14 from
16 macroalgal species (88% of the total) inhibited at least
one of the tested organisms (Fig. 1a, b). Antimicrobial
activity was demonstrated in members of the three
phylogenetic divisions of macroalgae (Chlorophyta,
Heterokontophyta and Rhodophyta, Table 2). Concerning
the test organisms, Gram-positive bacteria and in
Abbreviations / abreviaciones. Bs: Bacillus
subtilis, Sl: Staphylococcus lentus, Ea:
Erwinia amylovora, Ec: Escherichia coli,
Pa: Pseudomonas aeruginosa,  Ba: Bacillus
algicola, Pl: Paenibacillus lautus, Pm:
Pseudomonas marincola, Ab: Algicola
bacteriolytica y Pe: Pseudoalteromonas
elyakovii
Table 2. Antibacterial activity and growth stimulation effect of the dichloromethane extracts of macroalga against a standard
set of bacteria and a set of macroalga-associated bacteria. MTP: growth stimulation (+) = 20-49%, + = 50-79% ++ = ≥ 80%; 0 =
no biological activity; growth inhibition (-) = 20-49%, - = 50-79%, -- = ≥ 80% / Actividad antibacteriana y de estimulación del
crecimiento presentada por los diferentes extractos diclorometánicos de las macroalgas frente a un set estándar de cepas y uno de
bacterias asociadas a macroalgas. La estimulación en el crecimiento fue designada con (+) = 20-49%, + = 50-79%, ++ = ≥ 80%; 0 = sin
actividad biológica; la inhibición del crecimiento bacteriano con (-) = 20-49%, - = 50-79%, -- = ≥ 80%
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particular B. subtilis were most susceptible (Fig. 2). From
the standard set E. amylovora and E. coli were not
inhibited by any extract tested (Table 2, Fig. 2). Also, no
extract presented inhibition of the algal pathogens or the
other strains of the macroalga-associated set (Fig. 1b).
The extracts of P. nigra and S. latissima presented the
strongest inhibitory effect on the bacterial strains with
around 80% growth inhibition of B. subtilis (Table 2, Fig.
1a). No particular trend in the biological activity was
observed by taxonomical macroalgal division (Fig. 3).
Although growth inhibitory effects were generally weak
(only against 3 bacterial strains and less than 80% of
growth inhibition, Fig. 1a), there was a higher proportion
of macroalgal species which inhibited the standard test
strains (23.8% of the total tests performed) compared to
species associated with macroalga (0%, Fig. 2). Only 12%
of the algal species did not present any antibiotic activity
(Fig. 1, 3).
Interestingly, the present study revealed significant
growth stimulation of macroalga-associated bacteria
(Table 2, Fig. 1b). The totality of the extracts stimulated
the growth of at least two of the tested bacteria (Fig. 3).
While growth stimulation of the standard set of bacteria
was rare (22.5% of the total tests) - with the exception of
plant pathogen E. amylovora and just two cases of S.
lentus (Fig. 2) - it was common among bacteria associated
with macroalgae (77.5%), especially B. algicola and P.
marincola. Quite interestingly, also growth of the
macroalgal pathogens A. bacteriolytica and P. elyakovii
was stimulated by most of the macroalgal extracts (both
81.3% of the total), and surprisingly none of the macroalgal
extracts inhibited these two strains (Figs. 1, 2). The extract
of D. baillouviana presented the strongest stimulatory
growth effects on the bacterial strains with around 200%
growth stimulation of A. bacteriolytica (Fig. 1b).
Figure 2. Summary by bacterial strain of the effect on the growth performed with the macroalgal
extracts. To the left, standard set and to the right, macroalga-associated set. The bars represent
enhancement of growth (grey), inhibition of growth (dark stripes) and no significant variation of
growth (points) in comparison to negative controls. Absence of inhibitory/stimulatory activity is designated
with a black dot. A total of 48 tests were performed for each strain. See the list of abbreviation in Table
2 / Resumen del efecto en el crecimiento bacteriano según microorganismos producido por los extractos
macroalgales investigados. A la izquierda, set estándar y a la derecha, set macroalga-asociado. Las barras
representan estimulación del crecimiento (gris), inhibición del crecimiento (negro) y sin efecto significativo
(barras con puntos) en comparación a los controles negativos. La ausencia de actividad biológica fue designada
con un punto negro. Un total de 48 pruebas fue realizado para cada cepa.  Ver lista de abreviaturas en Tabla 2
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DISCUSSION
In the majority of prior studies, bacterial growth inhibiting
activities of different macroalgal extracts were
investigated on human pathogens or standard terrestrial
strains (Dubber & Harder 2008). In the present study, we
investigated the different effects macroalgal extracts can
display over the growth of bacteria especially by testing
ecologically relevant microorganisms. Hughes & Fenical
(2011) suggested recently that antibacterial activity can
only be evaluated in the context of the bacteria strains
that are selected. We demonstrated that one macroalgal
extract can display different effects on growth of
microorganisms especially by testing macroalga-
associated bacteria in comparison with a standard set of
bacteria.
In the present study, 88% of the macroalgae displayed
antibacterial activity against at least one of the test strains.
The antibiotic effect was observed only against 3 bacterial
strains from the standard set and less than 80% of
inhibition. Extracts of some macroalgal species usually
associated with high antimicrobial activity as Rhodomela
confervoides (Glombitza 1969) and Bonnemaisonia
hamifera (Nylund et al. 2005, Persson et al. 2011; Fig. 1a)
were active too. B. subtilis from the standard set was the
most susceptible to the macroalgal extracts (Fig. 2) in
accordance with other studies on macroalgae (Freile-
Pelegrin & Morales 2004, Dubber & Harder 2008, Sánchez-
Saavedra et al. 2010).
Just a few studies have investigated the biological
activities of macroalgal extracts of the German coasts,
and most of them have used standard bacteria. For
example, Roos (1957) investigated 27 species of
macroalgae of the Kiel Fjord, and tested them against
standard strains including Staphylococcus aureus, B.
subtilis and E. coli. Most species (82%) were active
Figure 3. Proportion of growth inhibition (dark stripes), enhancement of growth (grey), and no significant
variation of growth (points) of microorganisms exposed to extracts of different macroalgal species /
Proporción de la inhibición del crecimiento (barras negras), estimulación del crecimiento (barras grises), y la
ausencia de una variación significativa (barras con puntos) en el crecimiento de microorganismos expuestos a los
diferentes extractos macroalgales
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against at least one of the tested microorganisms. As in
the present study, Roos also found antibacterial activity
in F. serratus, F. vesiculosus, P. elongata, R. confervoides
(as R. subfusca), and S. latissima. Later, Glombitza (1969)
confirmed some of these results during a study with 41
macroalgae from the coastal zone of the Helgoland Island
in the German North Sea including C. rupestris, D.
contorta (as D. incrassata), S. latissima, F. vesiculosus,
and R. confervoides. The author also used standard
bacteria in the tests (i.e., Bacillus cereus, B. subtilis, E.
coli, Proteus vulgaris, Sarcina lutea, and S. aureus).
From the same German island, Duber & Harder (2008)
tested macroalgal extracts of Ceramium rubrum,
Mastocarpus stellatus and Laminaria digitata against 7
fish pathogenic bacteria and 12 bacteria from marine
sediments. Extracts of those 3 macroalgae presented high
activity against growth of different strains. In another
study, extracts of 4 German North Sea macroalgae (C.
rubrum, Hypoglossum hypoglossoides, S. latissima, and
Plocamium cartilagineum) were tested against 5 fish
pathogenic strains, inhibiting all the macroalgae at least
one bacterial strain, from which S. latissima was active
only against Vibrio anguillarum (Bansemir et al. 2006).
Although these studies clearly showed that macroalgae
commonly contain active metabolites with antibacterial
properties, it is not known whether the metabolites have
an active role within the ecological interactions with their
natural enemies (Jormalainen & Honkanen 2008), and/or
symbionts. Important variations in the effect of different
macroalgal extracts on different marine fouling
microorganisms have been shown by Hellio et al. (2000,
2001). In a study in the Caribbean Sea, the marine bacterial
strains (including P. elyakovii) selected were most
sensitive to extracts of Sargassum polyceratium
compared to a standard bacterial strains, suggesting that
defence strategies of this brown alga are specific (Thabard
et al. 2011). Such targeted defence strategies have been
described for some algal species before (see Paul & Puglisi
2004).
Different crude extracts tested in the present study
have significantly stimulated the growth of bacteria,
especially ecologically relevant strains (both surface
associated and pathogenic strains, Table 2). One of the
extract, of the introduced species D. baillouviana,
presented the strongest stimulatory effects on the
bacterial strains with ~ 200% growth stimulation of the
pathogen A. bacteriolytica (Fig. 1b). Although several
studies have shown stimulation of bacterial growth by
algae, unfortunately, they have been based generally on
exudates rather than extracts, and usually of
phytoplanktonic sources (see Bell et al. 1974, Larsson &
Hagström 1979, Brock & Clyne 1984, Murray et al. 1986,
Coveney & Wetzel 1989). Algal exudates, unknown or
partially specified, have been shown to significantly affect
the community structure of bacteria in biofilms and in the
pelagic zone near the macroalgae (see Dobretsov et al.
2006, Lam & Harder 2007, Lachnit et al. 2010, Persson et
al. 2011, Saha et al. 2011, Sneed & Pohnert 2011a, b). It is
well known that macroalgae release large amounts of
organic carbon into the surrounding environment,
providing nutrients for microorganisms (Koop et al. 1982,
Wada et al. 2007). Heterotrophic bacteria can directly utilize
products excreted by algae as growth substrates (Larsson
and Hagström 1979, Brock & Clyne 1984). Excreted
compounds may also trigger chemotactic behaviour and
stimulate growth (Goecke et al. 2010). These compounds
are quite selective in their stimulation of bacteria, because
different bacteria differ considerably in their ability to
respond to these products (Bell et al. 1974). The strain-
specific preferences for certain substrates and strain
specific pro- or antifouling activities of algal metabolites
play an important role in establishing ecological
associations (Wahl et al. 2010). It has been suggested
that chemical defences may affect marine communities
by promoting some microbes on algal surfaces while
deterring others (Lane & Kubanek 2008). However, after
more than 20 yrs of research on this topic, there is still no
experimental evidence demonstrating if or how host
organisms selectively attract and harbour their epibionts
(Harder 2009); especially because the studies focussed
on inhibitory activities of extracts or metabolites and rarely
were concerned with stimulatory effects on growth of the
microorganisms.
The bacterial growth stimulatory effect may have
different explanations. As mentioned recently, those
organic extracts and compounds may rather resemble dead
algal material available for microbial degradation
(Bengtsson et al. 2011). Nevertheless, the possibility of
the presence of certain algal substances that specifically
stimulate a selected array of species or even strains has
also been suggested recently (see Sneed & Pohnert
2011b).
In the present study, we tested activities of macroalgal
extracts against two macroalgal pathogens: A.
bacteriolytica (formerly Pseudoalteromonas
bacteriolytica) and P. elyakovii. All studied macroalgae
revealed no inhibitory activities against these pathogens;
on the contrary, growth stimulatory activities were in
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general displayed (Fig. 1b). The extract of S. latissima,
which was the only studied brown macroalga that belong
to Laminariales, stimulated growth of both macroalgal
pathogens (but <30%). Members of this genus were
originally affected by those pathogens (Sawabe et al.
1998, 2000). Recently, in tropical environments, extensive
investigations of different macroalgal extracts have shown
high biological activity against A. bacteriolytica (Engel
et al. 2006, Puglisi et al. 2007, Lane et al. 2010). This
indicates highly variable amounts and different
composition of active compounds, probably depending
on the biotic and abiotic pressures onto the macroalgae.
It is accepted that chemical defences are elaborated to a
greater extent and are more important in tropical than
temperate or cold areas as in the German coast (see Pereira
& da Gama 2008). Unfortunately, with the exception of
one study using causative agents of the macroalgal ice-
ice disease (by Vairappan et al. 2010) and P. elyakovii
(by Thabard et al. 2011), bioactivity tests of algal extracts
or compounds against other known bacterial pathogens
of macroalgae were rarely performed.
As recommended by Engel et al. (2006) caution must
be exercised about drawing ecological conclusions of the
role of secondary metabolites on the observed biological
activity. The concentration used in our assays followed
standard procedure (see Bansemir et al. 2006, Muñoz-
Ochoa et al. 2010, Sánchez-Saavedra et al. 2010, Villarreal-
Gómez et al. 2010), and crude extracts are usually complex
mixtures of compounds. Therefore it is unknown which
substances at which concentration exhibited the
bioactivity in nature (Persson et al. 2011). Despite the
inconveniences using crude extracts of whole organism
already mentioned by several authors (see Paul et al.
2006, Lane et al. 2009, Nylund et al. 2010), there is no
doubt that such experiments provide insights into the
potential interactions mediated by algal metabolites,
especially by using environmental test strains. We
confirmed that macroalgal extracts exert effects of growth
inhibition and stimulation according to the nature of the
bacterial strains selected. We demonstrated that
macroalgal extracts have growth stimulant effects on
macroalga-associated bacteria including algal pathogens.
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